Opens in a new tab

Dr. Lin Haotian

Chinese name: 林浩添
Professor, Chief Physician, Doctoral Supervisor . Cataract Surgery & Ocular AI
Dr. Lin Haotian is Director of the Zhongshan Ophthalmic Center and the Eye Hospital of Sun Yat-sen University, and Director of the State Key Laboratory of Ophthalmology. A cataract surgeon and leader in medical artificial intelligence, he develops AI technologies for the screening and treatment of blinding eye diseases and has published widely as first or corresponding author.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

200+
First/corresponding-author SCI publications
47
Granted domestic and international patents
50+ million
AI-driven eye disease screening and diagnosis

  • The Physician

About Dr. Lin Haotian

Dr. Lin Haotian is Director of the Zhongshan Ophthalmic Center and the Eye Hospital of Sun Yat-sen University, Director of the Eye Institute and Director of the State Key Laboratory of Ophthalmology. A cataract specialist, he leads the centre's work in medical artificial intelligence and big data. His team develops AI systems for the screening, diagnosis and management of blinding eye diseases, and he co-authored landmark research on lens regeneration published in Nature. He has published more than 150 SCI papers as first or corresponding author and holds several national research grants, including the National Key Research and Development Programme.
1、Director of the Zhongshan Ophthalmic Center and the Eye Hospital of Sun Yat-sen University
2、Director of the State Key Laboratory of Ophthalmology and the Eye Institute
3、Leader in medical artificial intelligence and big data for eye care
4、Co-author of landmark lens regeneration research published in Nature
5、Author of more than 150 SCI papers as first or corresponding author
6、Recipient of the China May Fourth Youth Medal and national high-level talent recognition

Dr. Lin Haotian ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Cataract surgery

He performs phacoemulsification and complex cataract surgery, including congenital, hard-nucleus and post-glaucoma cataracts, restoring vision with individualized intraocular lens selection and careful management of coexisting eye disease, and integrates digital tools to safely improve surgical planning, long-term follow-up and outcomes.

Artificial intelligence in ophthalmology

He develops and validates deep-learning systems for cataract screening, surgical evaluation and eye disease diagnosis, aiming to extend specialist eye care to underserved regions through intelligent, low-cost and accessible screening platforms that support early detection and timely referral for patients at scale.

Blinding eye disease prevention

He leads population-based programmes for the prevention and control of blindness, integrating telemedicine, big data and affordable community screening to detect, monitor and treat cataract, glaucoma and retinal disease early and link patients to specialist treatment for patients of all ages across Guangdong and beyond.

More: congenital cataract——diagnosis and surgery; refractive error——lens selection; paediatric eye screening——AI tools; teleophthalmology——remote care; eye health big data——research

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Optimal Timing and Surgical Approach for Congenital Cataract Surgery in Infants
A prospective randomized trial at Zhongshan Ophthalmic Center compared congenital cataract surgery performed at 3 versus 6 months of age using three surgical approaches. Results showed bilateral complete congenital cataract children had better visual outcomes when cataract surgery was delayed to 6 months, guiding safer pediatric cataract treatment and reducing amblyopia risk.
2. AI Platform for Multihospital Collaborative Management of Congenital Cataracts
Zhongshan Ophthalmic Center researchers built an artificial intelligence platform using deep learning for congenital cataract diagnosis, risk stratification and treatment suggestions. Validated in a multihospital clinical trial, the AI agent matched individual ophthalmologists’ performance and improved congenital cataract care, supporting AI eye screening and referral for pediatric cataract patients in underserved regions.
3. AI-Assisted Childhood Cataract Diagnosis in Real-World Eye Clinics
A multicentre randomized controlled trial in five Chinese eye clinics compared CC-Cruiser, an artificial intelligence platform, with senior consultants for diagnosing childhood cataracts. CC-Cruiser delivered cataract diagnosis in 2.79 minutes with high patient satisfaction, showing AI eye screening and treatment support can assist clinicians facing heavy pediatric cataract workloads.
4. AI Telehealth System for Postoperative Congenital Cataract Follow-Up
Using Bayesian and deep-learning algorithms, Zhongshan Ophthalmic Center developed CC-Guardian, an AI agent for congenital cataract follow-up. It predicts postoperative complications such as high intraocular pressure and visual axis opacification, schedules individualized follow-up and guides telehealth intervention, cutting socioeconomic burdens while improving outcomes after pediatric cataract surgery.
5. Smartphone Deep Learning System for Early Detection of Visual Impairment in Young Children
Zhongshan Ophthalmic Center researchers created Apollo Infant Sight, a smartphone-based deep learning system that screens young children for visual impairment by analyzing gazing behavior and facial features. Validated on 3,652 children across China, it supports early AI eye screening for congenital cataract, strabismus and other pediatric eye disorders, helping parents detect problems sooner.
6. AI-Guided Capsulorhexis System Improving Cataract Surgery Precision
Zhongshan Ophthalmic Center teams developed MetaS, an intelligent system that digitizes ideal capsulorhexis features from 17,538 cataract surgery videos, guiding surgeons and surgical robots for more accurate, centered capsulorhexis. This AI surgical navigation improves cataract surgery precision and stability, benefiting patients receiving functional intraocular lens implantation.
  • Affiliated Hospital

Where Dr. Lin Haotian practices

Guangzhou

Zhongshan Ophthalmic Center, Sun Yat-sen University

Chinese name: 中山大学中山眼科中心
Zhongshan Ophthalmic Center, China's largest public eye hospital and the country's only WHO Collaborating Centre for Eye Health and Vision, performs 100,000+ surgeries a year with a 93.83% day-surgery rate and serves 1.4 million annual outpatient visits.
Since 1835
191 years of eye care
100,000+
Annual eye surgeries
1.4 million
Annual outpatient visits
93.83%
Annual eye surgeries
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Lin Haotian?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Lin Haotian.